Daily interferon alpha 2b and Ribavirin combination therapy for chronic hepatitis C patients who have relaped or not responded to previous treatment: One year treatment results
Karasu, Zeki, Gurakar, Ahmet O., Jazzar, Ahmad S., Emmett, Carolyn, McMillon, Greg C., Nour, Bakr M., Wright, Harlan I.Volume:
118
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(00)81717-5
Date:
April, 2000
File:
PDF, 164 KB
english, 2000